KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Gross Margin (2016 - 2026)

Evolent Health has reported Gross Margin over the past 11 years, most recently at 20.75% for Q4 2025.

  • For Q4 2025, Gross Margin rose 904.0% year-over-year to 20.75%; the TTM value through Dec 2025 reached 21.31%, up 693.0%, while the annual FY2025 figure was 21.31%, 693.0% up from the prior year.
  • Gross Margin for Q4 2025 was 20.75% at Evolent Health, roughly flat from 20.81% in the prior quarter.
  • Over five years, Gross Margin peaked at 33.77% in Q4 2021 and troughed at 11.71% in Q4 2024.
  • A 5-year average of 22.07% and a median of 22.22% in 2021 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: tumbled -1205bps in 2022 and later surged 904bps in 2025.
  • Year by year, Gross Margin stood at 33.77% in 2021, then crashed by -36bps to 21.72% in 2022, then decreased by -16bps to 18.28% in 2023, then plummeted by -36bps to 11.71% in 2024, then surged by 77bps to 20.75% in 2025.
  • Business Quant data shows Gross Margin for EVH at 20.75% in Q4 2025, 20.81% in Q3 2025, and 22.59% in Q2 2025.